COMPARISON OF THE EFFECTS OF ERECTOR SPINAE PLANE (ESP) BLOCK AND QUADRO İLİAC PLANE (QIP) BLOCK ON POSTOPERATIVE OPIOID CONSUMPTION AND PAIN IN LUMBAR SPINAL SURGERY
COMPARISON OF THE EFFECTS OF ERECTOR SPINAE PLANE (ESP) BLOCK AND QUADRO ILIAC PLANE (QIP) BLOCK ON POSTOPERATIVE OPIOID CONSUMPTION AND PAIN IN LUMBAR SPINAL SURGERY
COMPARISON OF THE EFFECTS OF ERECTOR SPINAE PLANE (ESP) BLOCK AND QUADRO İLİAC PLANE (QIP) BLOCK ON POSTOPERATIVE OPIOID CONSUMPTION AND PAIN IN LUMBAR SPINAL SURGERY
研究概览
地位
条件
详细说明
The study is designed as a double-blind, prospective, randomized controlled trial. Regarding blinding, the healthcare personnel responsible for monitoring postoperative pain will be unaware of whether the patients received an ESP block or a QIP block. Patient randomization was planned using a computer-based system. Following the operation, once patients are transferred to the postoperative recovery room, their pain levels will be assessed and recorded using the Numeric Rating Scale (NRS) at the following time points: 30 minutes, and 1, 6, 12, and 24 hours. In the ward, patients will receive tramadol via PCA and paracetamol every eight hours. Hourly NRS monitoring is planned during the patient's follow-up in the ward. If the NRS score reaches 4 or higher during this period, 75 mg of diclofenac sodium will be administered intramuscularly, and the number of self-administered bolus doses via PCA (Patient-Controlled Analgesia) within the first 24 hours will be recorded. Opioid consumption and pain levels (via NRS scores) will be evaluated at the 24th postoperative hour for patients in both the ESP and QIP block groups. Additionally, the patients' hemodynamic parameters will be recorded at these time intervals.
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:SİNEM SARI PROF DR
- 电话号码:902564441256
- 邮箱:sarisinem@yahoo.com
学习地点
-
-
-
Aydin、土耳其(türkiye)、09100
- Aydin Adnan Menderes Üniversitesi Tip Fakültesi Hastanesi
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Undergoing elective lumbar spinal surgery
- ASA I-III
- Aged 18-75 years Exclusion Criteria: - 1. Refusal at the time of enrollment 2. Request to withdraw from the study 3. Inability to provide informed consent 4. Emergency surgery 5. Bleeding diathesis 6. Presence of contraindications to the local anesthetic (LA) agents used in this study 7. Chronic opioid use 8. Psychiatric disorders 9. Presence of infection at the injection site
学习计划
研究是如何设计的?
设计细节
- 主要用途:预防
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:双倍的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
有源比较器:ESP BLOCK
|
An 11-point Numerical Rating Scale (NRS), where 0 indicated no pain and 10 represented the worst pain imaginable, was used to assess patients' pain levels. The total number of patient-controlled analgesia (PCA) bolus doses delivered within the first 24 hours will record All patients in the ward will be administered intravenous paracetamol every 8 hours, and intramuscular diclofenac sodium (75 mg) if the NRS score is 4 or higher.
其他名称:
|
|
实验性的:QIP BLOCK
|
An 11-point Numerical Rating Scale (NRS), where 0 indicated no pain and 10 represented the worst pain imaginable, was used to assess patients' pain levels. The total number of patient-controlled analgesia (PCA) bolus doses delivered within the first 24 hours will record All patients in the ward will be administered intravenous paracetamol every 8 hours, and intramuscular diclofenac sodium (75 mg) if the NRS score is 4 or higher.
其他名称:
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
To compare the effects of the Quadro İliac Plane Block and the Erector Spinae Plane (ESP) Block on postoperative opioid consumption in lumbar spinal surgeries
大体时间:24 hour
|
All patients will be administered tramadol via PCA, and the amount of tramadol consumed will be assessed at the end of the 24-hour postoperative period. |
24 hour
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
To compare the effects of the Quadro iliac (Qıp) block and the Erector Spinae Plane (ESP) block on postoperative pain in lumbar spinal surgeries
大体时间:12th hour
|
The NRS score will be assessed on a scale of 0 to 10, with 0 representing the lowest and 10 the highest value; patients will be asked to provide a rating at the 12th hour. |
12th hour
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- 2026/302
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.